• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Bank of Marin Bancorp (Amendment)

    4/30/24 6:03:04 PM ET
    $BMRC
    Major Banks
    Finance
    Get the next $BMRC alert in real time by email
    SC 13D/A 1 sc13da213168002_04302024.htm AMENDMENT NO. 2 TO SCHEDULE 13D

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 2)1

    Bank of Marin Bancorp

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    063425102

    (CUSIP Number)

    STEVE WOLOSKY, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    April 26, 2024

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 063425102

      1   NAME OF REPORTING PERSON  
             
            Riley Gardner  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         448,254  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              448,254  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            448,254  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            2.8%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    2

    CUSIP No. 063425102

      1   NAME OF REPORTING PERSON  
             
            Shawn Devlin  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         566,031  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              566,031  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            566,031  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.5%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    3

    CUSIP No. 063425102

     

    The following constitutes Amendment No. 2 to the Schedule 13D filed by the undersigned (“Amendment No. 2”). This Amendment No. 2 amends the Schedule 13D as specifically set forth herein.

    Item 4.Purpose of Transaction.

    Item 4 is hereby amended to add the following:

    On April 26, 2024 the Reporting Persons and the Issuer entered into an amendment (“Amendment No. 3”) to that certain previously disclosed agreement dated May 10, 2021 (as amended by Amendment No. 1 dated March 31, 2022 and Amendment No. 2 dated April 25, 2023, the “Agreement”) under which, among other things, Sanjiv Sanghvi was added to the Issuer’s Board of Directors (the “Board”) and included in the Issuer’s slate of directors for election to the Board at the 2021 Annual Meeting of Shareholders. Amendment No. 3 provides for, among other things, the confirmation of Mr. Sanghvi as the continuing Kelly Trust Nominee (as defined in the Amendment) (including as one of the Board’s nominees for the 2024 Annual Meeting of Shareholders), the continuing appointment of Mr. Sanghvi to the Bank of Marin Board of Directors and the extension of the “Restricted Period” by approximately one year. The other terms and conditions of the Agreement generally were continued. The summary description of Amendment No. 3 in this paragraph is qualified in its entirety by reference to the full terms of Amendment No. 3, which is attached as Exhibit 99.1 hereto and incorporated herein by reference.

    Item 5.Interest in Securities of the Issuer.

    Items 5(a) – (c) are hereby amended and restated to read as follows:

    The aggregate percentage of Shares reported owned by each person named herein is based upon 16,297,287 Shares outstanding as of March 25, 2024, which is the total number of Shares outstanding as reported in the Issuer’s Definitive Proxy Statement, filed with the Securities and Exchange Commission on April 9, 2024.

    A.Mr. Gardner
    (a)As of the date hereof, Mr. Gardner directly beneficially owned 448,254 Shares.

    Percentage: Approximately 2.8%

    (b)1. Sole power to vote or direct vote: 448,254
    2. Shared power to vote or direct vote: -0-
    3. Sole power to dispose or direct the disposition: 448,254
    4. Shared power to dispose or direct the disposition: -0-
    (c)Mr. Gardner has not entered into any transactions in the securities of the Issuer during the past 60 days.
    B.Ms. Devlin
    (a)As of the date hereof, Ms. Devlin directly beneficially owned 566,031 Shares.

    Percentage: Approximately 3.5%

    4

    CUSIP No. 063425102

    (b)1. Sole power to vote or direct vote: 566,031
    2. Shared power to vote or direct vote: -0-
    3. Sole power to dispose or direct the disposition: 566,031
    4. Shared power to dispose or direct the disposition: -0-
    (c)Ms. Devlin has not entered into any transactions in the securities of the Issuer during the past 60 days.

    The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or she does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or she does not directly own.

    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

    Item 6 is hereby amended to add the following:

    On April 26, 2024, the Reporting Persons and the Issuer entered into Amendment No. 3, as defined and described in Item 4 above and attached as Exhibit 99.1 hereto.

    Item 7.Material to be Filed as Exhibits.

    Item 7 is hereby amended to add the following:

    99.1Amendment No. 3, dated April 26, 2024 (incorporated by reference to Exhibit 10.1 of the Issuer’s Form 8-K filed with the Securities and Exchange Commission on April 30, 2024).

     

    5

    CUSIP No. 063425102

    SIGNATURES

    After reasonable inquiry and to the best of their respective knowledge, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: April 30, 2024

     

    /s/ Riley Gardner

      Riley Gardner
       
       
     

    /s/ Shawn Devlin

      Shawn Devlin

     

    6

    Get the next $BMRC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BMRC

    DatePrice TargetRatingAnalyst
    12/9/2024Equal-Weight → Overweight
    Stephens
    10/10/2024$24.00Neutral → Buy
    DA Davidson
    3/2/2023Neutral → Buy
    Janney
    12/28/2021$40.00Equal-Weight
    Stephens
    12/21/2021$45.00Outperform
    Keefe Bruyette
    7/20/2021$43.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings